Teresa Gagliano
Udine, 33100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Epigenetics and the Tumor Microenvironment in Neuroendocrine Tumors.
Journal: Cancers
Published: November 21, 2025
Spleen tyrosine kinase (SYK) inhibition suppresses growth of gastrointestinal neuroendocrine tumor cells: a pilot study in two cell lines.
Journal: Cancer gene therapy
Published: September 01, 2025
FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETs.
Journal: Endocrine oncology (Bristol, England)
Published: May 21, 2025
Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 08, 2024
Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 24, 2023
Editorial: Gender pressure in cancer: susceptibility, progression and treatment of the neoplastic disease.
Journal: Frontiers in endocrinology
Published: July 31, 2023
Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment.
Journal: Cancer gene therapy
Published: January 26, 2023
HDACs and the epigenetic plasticity of cancer cells: Target the complexity.
Journal: Pharmacology & therapeutics
Published: February 15, 2022
The multifaceted role of lemur tyrosine kinase 3 in health and disease.
Journal: Open biology
Published: September 28, 2021
Correction to: LMTK3 inhibition affects microtubule Stability.
Journal: Molecular cancer
Published: April 10, 2021
Cancer gene therapy 2020: highlights from a challenging year.
Journal: Cancer gene therapy
Published: March 11, 2021
Last Updated: 09/26/2026